Navigation Links
ViaCyte's Role as a Leading Cell Therapy Company Bolstered with the Issuance of 20 Patents in 2012
Date:1/31/2013

SAN DIEGO, Jan. 31, 2013 /PRNewswire/ -- ViaCyte, Inc., a leading regenerative medicine company focused on developing new approaches to treat major diseases through the application of a stem cell-derived cell therapy, announced today that the Company was granted 20 patents worldwide in 2012, eight U.S. and twelve foreign.  These patents bolster the Company's already strong proprietary position for its ground-breaking diabetes product, VC-01, as well as other applications of its broad technology platform.

(Logo: http://photos.prnewswire.com/prnh/20121026/LA00871LOGO-a)

VC-01 is a very promising, development-stage product that consists of pancreatic precursor cells (called PEC-01) derived from a proprietary human embryonic stem cell line and encapsulated in a proprietary, immune isolating medical device (the ENCAPTRA® device).  When implanted under the skin in suitable animal models, the cells further differentiate into insulin producing and other endocrine cells that regulate blood glucose in a manner similar or identical to a normal pancreas.  If VC-01 performs in humans as it has in animal studies, it could effectively cure type 1 diabetics and be an important new therapy for insulin dependent type 2 diabetics.

ViaCyte's significant intellectual property portfolio now includes over 300 issued patents and pending applications related to the growth, directed differentiation and use of human pluripotent stem cells such as human embryonic stem cells and induced pluripotent stem cells.  This portfolio includes 51 issued U.S. and foreign patents specifically directed to the Company's VC-01 product.  In addition to the protection afforded by patents, the Company also relies on significant proprietary know-how to develop its product offerings.

Dr. Paul Laikind , ViaCyte's pres
'/>"/>

SOURCE ViaCyte, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Leading Investigator to Present Clinical Data on Generex Oral-lyn™ at International Diabetes Federation Meetings in Dubai
2. BioSpace Spotlights Leading Life Science Community
3. Northwest Bio Reaffirms Its Freedom to Operate; Refutes Other Parties Misleading Patent Assertions
4. iBioSeminars and iBioMagazine: Free, Online Biology Seminars and Short Talks by Leading Scientists
5. Leading Pharmaceutical Marketing Research and Consulting Company Introduces Intelligent Efficiency Program
6. Johns Hopkins Health System is 100th healthcare Provider to Integrate OnBase With Leading Electronic Medical Record System
7. Leading German Researcher Awarded Elseviers 2011 Tetrahedron Prize
8. Dyadic International Partners with Leading Provider of Nutritional Ingredient Solutions for Production of Food Enzymes
9. Floridas Leading Fertility Center Announces Successful Baby Delivery via Egg Freezing
10. Life Technologies Showcases Leading Technologies for Cancer Research at the AACR Annual Meeting 2012
11. Urologists Debunk Misleading, Grossly Inaccurate Prostate Cancer Biopsy Study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... (PRWEB) January 15, 2014 Look inside ... hard-working items for the lab, from fluid handling to ... (GIS)—ready to ship when you order. , Preferred ... Pumps , from the L/S® model for precise flow ...
(Date:1/15/2014)... Jan. 15, 2014 ­ RedBrick Health , a ... technology, today announces that EmblemHealth , the ... company, is now providing the RedBrick Compass health assessment, ... to all of its members. EmblemHealth is among the ...
(Date:1/15/2014)... More than 5 million Americans are currently living ... will die with Alzheimer’s or another dementia, according to ... many Americans into looking for ways to improve their ... cognitive disorders. Jonathan Weisman, president of Biohack Pure, is ...
(Date:1/15/2014)... January 15, 2014 DTS Language Services, ... Online Web Portal for Life Science organizations who need document ... the subject matter of their documents in advance with a ... reduce time-to-delivery of translations, often a critical factor in clinical ...
Breaking Biology Technology:Cole-Parmer Begins 2014 with the Release of Preferred Solutions 2EmblemHealth Selects RedBrick Health to Power its Next-Generation Health Engagement and Behavior Change System 2EmblemHealth Selects RedBrick Health to Power its Next-Generation Health Engagement and Behavior Change System 3Biohack Pure Offers 5 Tips for Increasing Memory in 2014 2DTS Improves Efficiency for Life Science Document Translations 2
... - Nerites Corp ., a Madison biotechnology company, has ... of funding, bringing the total raised to $3 million in ... clinical trials to verify the efficacy of two products: adhesives ... such as blood, and medical device coatings that block bacterial ...
... Madison, Wis. - Wisconsin's information technology and ... recruiting the talent to leverage IT has become ... and a decline in IT enrollment could leave ... and technical college systems graduate fewer qualified workers ...
... blessed with majestic mountains, fertile valleys, sulfurous lava fields, and ... a day-and-a-half on airplanes (thank God I was able to ... in another world. This is definitely not Kansas Frodo; in ... New Zealand. After dashing through customs, I am back on ...
Cached Biology Technology:IT worker shortage linked to tech enrollment drop 2IT worker shortage linked to tech enrollment drop 3IT worker shortage linked to tech enrollment drop 4IT worker shortage linked to tech enrollment drop 5An upside down view of the future 2An upside down view of the future 3An upside down view of the future 4An upside down view of the future 5
(Date:4/23/2014)... is available in French and Spanish ... 23 April 2014Today, the CEC released its Conservation Assessment ... Approach to Conservation, which identifies 29 priority conservation areas ... includes 11 different protected areas in the states of ... diverse arid and semi-arid habitats inhabited by rare and ...
(Date:4/23/2014)... 2014) People who have had a stroke, often ... function. However, a study conducted in Taiwan, that will ... Transplantation , but is currently freely available on-line as ... found that when one group of stroke victims had ... into the brain and a similar group did not, ...
(Date:4/23/2014)... At a signing ceremony in Buenos Aires yesterday, ... as an associate member state. The move strengthens ... life science communities. It grants Argentinian scientists access ... mutually beneficial collaborations. , "Ever since its inception, ... internationalisation have been at the core of EMBL,s ...
Breaking Biology News(10 mins):Conservation priorities released for several protected areas along US-Mexico border 2Conservation priorities released for several protected areas along US-Mexico border 3Autologous stem cell therapy improves motor function in chronic stroke victims 2
... For several years, many have been quick to attribute ... increases in childhood obesity. Now researchers at the University ... consumption is simply a byproduct of a much bigger ... homes. The study, led by Barry Popkin, W.R. ...
... in 2011 and 2012 made two unexpected discoveries that could ... and aid in the creation of a plan to protect ... along a transect that stretched from the open ocean, across ... bays and inlets around the Rock Islands of Palau, in ...
... Early explorers of Amazonian plants and animals included renowned naturalists ... Wallace. Despite this long history of exploration, new studies are ... species. The key of these discoveries lies in the use ... published in the open access journal ZooKeys ...
Cached Biology News:Fast food not the major cause of rising childhood obesity rates 2Coral reefs in Palau surprisingly resistant to naturally acidified waters 2Coral reefs in Palau surprisingly resistant to naturally acidified waters 3Coral reefs in Palau surprisingly resistant to naturally acidified waters 4Genes and calls reveal 5-fold greater diversity of Amazon frog species 2
Rabbit polyclonal to Presenilin 1, prediluted ( Abpromise for all tested applications). entrezGeneID: 5663 SwissProtID: P49768...
Mouse monoclonal [LPL4A.1] to Plastin L ( Abpromise for all tested applications). SwissProtID: P13796...
... designed for use with the ProQuest Two-Hybrid ... contains deletions in the endogenous GAL4 and ... systems. The strain also has leu2 and ... and prey vectors. MaV203 contains three GAL4 ...
Request Info...
Biology Products: